INTRODUCTION Procedures
Each accepted research report was reviewed and coded according to 6 criteria 1. At least 1 target variable (TST, sleep latency, sleep efficiency, WASO, REM sleep, stage 1 sleep, stage 2 sleep, SWS) was present 2. The sample was well described (number of subjects, recruitment procedure, etc) 3. Statistical analytic results were reported for at least 1 target variable (for example, F value, r value, etc); 4. Central tendency measures (eg, mean) and measures of variability were reported for at least 1 target variable;
5. Sexes were identified, and data summarized for each 6. Age was identified, and data summarized for age groups Research reports with positive answers to criteria 1 to 4 and positive answers on criteria 5 or 6 were analyzed with a detailed checklist composed of 15 items summarizing the key elements of the articles: background, participants, intervention, selection criteria, objectives, outcomes, sample size, composition of the sample, variables assessed, statistical methods, and key results. As a rule, when the studies included 2 or more nights of PSG recording, the first-night results were discarded from the meta-analysis. When the results for each night were presented, night-1 results were discarded, and the data were averaged for all the other nights.
Statistical Analyses

Calculation of Effect Sizes
Effect sizes are indices that measure the magnitude of the differences between 2 groups. Effect sizes can be measured in 2 ways: (1) as the standardized differences between 2 groups or (2) as the correlation between an independent variable classification and individual scores on the dependent variable (effect size correlation). For this study, we measured standardized differences between 2 groups by calculating Cohen's d. 45 The simplest formula of Cohen's d is defined as the difference between means (M1 -M2) divided by the SD of either group. Furthermore, since the different groups in the selected studies are presumed to come from the same population (healthy individuals), pooled SD was used instead. 46 The pooled SD is the root mean square of the 2 SD. The formula is then: d = M 1 -M 2 / σ pooled where σ pooled = √[( σ 1 2 + σ 2 2 ) / 2]. Some studies did not provide means and SD for the key variables; therefore, effect size had to be calculated from other statistical tests reported, such as correlation coefficients, t tests, or analyses of variance.
Analyses of Effect Sizes
Effect sizes for each study were analyzed using Comprehensive Meta Analysis, a software package developed by Biostat (Englewood, NJ). The software provides a correction of effect sizes for sampling errors, 47 particularly important since most studies had small sample sizes. The formula given by Hedges and Olkin 47 was used: unbiased estimate of d = d × (1 -[3 /{4 (M 1 + M 2 )-9}]). Values of d are interpreted according to Cohen guidelines: 45 effect sizes at .2 are considered small, at .5 are considered medium, and are large at .8. In the text, as a general rule, a positive value of the effect size indicates an increase with age of the studied variable while a negative value indicates a decrease with age. The closer an effect size is to 0, the smaller is the age difference.
The Q statistic, a homogeneity test, was calculated to assess the dispersion of individual outcomes vis-à-vis the combined effect. The Q statistic has an approximate χ 2 distribution with k-1 degrees of freedom where k is the number of effect sizes. When Q is significant, it indicates that the variation is greater than expected by sampling error and that analyses of moderators should be done. Therefore, 7 moderator variables that might influence sleep parameters were also collected: mental illness, physical illness, drugs or alcohol use, sleep apnea, other sleep disorders, sex, and polysomnographic recordings performed according a fixed sleep-wake schedule or based on habitual sleep patterns. For children and adolescents, the time of the recording (school day vs nonschool day) was also collected. These moderators were used to calculate to what extent their presence (or absence) modified the different effect sizes. Alpha was set to .05 for all analyses, and the confidence intervals to 95%.
RESULTS
Only 10.8% of the studies were conducted in 1975 or earlier; 16 .9% were performed between 1976 and 1985; 33.8% of studies were carried out between 1986 and 1995; and 38.5% between 1996 and 2003. Table 1 presents the number of studies and subjects involved for each moderator variables.
Studies in Children and Adolescents
Data collection of objective sleep parameters was relatively infrequent in children and adolescents. A total of 18 studies presenting numeric data on TST and sleep stages were found from 1972 to 2003 (Table 2 ). In addition, the instrumentation used to collect sleep data varied. Eleven studies used in-laboratory PSG recording. Two studies used an ambulatory monitoring system, 55, 58 and 5 studies used actigraphy, 1 of them using both inlaboratory polysomnographic recording and actigraphy. 57, [60] [61] [62] 64 The 18 studies were performed in different contexts. Five studies were done only on school days, 53,58,60-62 3 studies were performed on week ends or during summer time, 54, 52, 59 and 2 studies included both school days and nonschool days. 57, 64 Eight studies did not specify the time of the year.
Studies in Adults
Forty-seven studies using either PSG or actigraphy recording of sleep parameters in healthy adults were retained. A listing of these studies can be found in Table 3 . In these studies, 17 (36.2%) compared sleep parameters of elderly adults to those observed in young adults (mostly subjects in their 20s). Seven (14.9%) compared young, middle-aged, and elderly subjects, 3 studies compared middle-aged subjects to elderly, 11 other studies were limited to young and middle-aged adults, and 9 included only elderly subjects. Most of the studies included both men and women but rarely reported values for each sex. Thirteen studies included only men and 1 study only women.
Six studies reported results based on a single night of polysomnographic recording (Table 3 ). In the other studies, the first night was for habituation to the laboratory, and the analyses were carried on the other nights. All but 5 of the PSG studies used the Rechtschaffen and Kales criteria 75 for sleep-stage scoring.
Overall Age-Related Trends
To describe age-related changes, we plotted mean values of each of sleep variables (TST; sleep latency; sleep efficiency; percentage of S1, S2, SWS, and REM sleep; and REM latency) as a function of age. The method of least squares was used to fit exponential equations to the data. Figure 1 presents the data and Table  4 the details of the equations. As is seen, sleep latency and percentage of S1, S2, and REM sleep had a low proportion of variance explained by age only (11% or less).
As can be observed, TST (r = -.76, P < .0001), sleep efficiency (r = -.82, P < .0001), percentage of SWS (r = -.56, P < .0001), and percentage of REM sleep (r = -.34, P < .0001) each showed a significant decrease with age. On the other hand, sleep latency (r = .16, P < .0001), percentage of stage 1 sleep (r = .16, P < .0001), percentage of stage 2 sleep (r = .34, P < .0001), and WASO (r = .75, P < .0001) each increased with age. Table 5 and 6 provide information about the effect sizes calculated for each of the 9 sleep variables studied, the number of studies and subjects involved, the mean weighted effect sizes with 95% confidence intervals, and the Q values of homogeneity tests.
Magnitude of Effect Sizes
Age Trends for Children and Adolescents
In children and adolescents, TST (n = 1360), percentage of SWS (n = 585), and REM latency (n = 447) were negatively correlated with age, which indicated that as the children are aging, these sleep variables are decreasing ( Table 5 ). Percentage of stage 2 sleep (n = 572) was positively related to age, indicating that percentage of stage 2 increases with age. The effect size was in the small range for percentage of REM sleep, indicating that the differences between children and adolescents, although significant, were not so large (about 2%). Effect sizes were in the medium range for TST, percentage stage 2 sleep, REM latency, and SWS. The decrease in SWS and the increase in percentage of stage 2 were about 7% per 5-year period between 5 and 15 years of age. Sleep latency, sleep efficiency, and percentage of stage 1 sleep had nonsignificant effect sizes. 
Age Trends for Adults
In adults, all sleep parameters had effect sizes significantly different from 0. The effect size was in the large range for TST, sleep efficiency, percentage of SWS, and WASO; medium for REM percentage; and small for percentage of stage 1 sleep and REM latency. Total sleep time, sleep efficiency, percentage of SWS, percentage of REM sleep, and REM latency were negatively correlated with age. This pattern indicates an age-related decrease in these sleep variables.
As seen in Figure 1a , TST (n = 2009) linearly decreased with age with a loss of about 10 minutes per decade of age. Similarly, percentage of SWS (n = 1544) linearly decreased at a rate of about 2% per decade of age. The decrease in sleep efficiency (n = 1738) was more evident from 40 years of age: a 3% decrease per decade of age can be observed until very old age. The decrease in percentage of REM sleep (n = 1986) was subtler and was more obvious when young adults were compared to individuals 60 years of age or older, where a 4% discrepancy can be observed between these 2 groups.
On the other hand, sleep latency (n = 1436), percentages of stage 1 (n = 1072) and stage 2 sleep (n = 1133), and WASO (n = 1012) increased with age, as indicated by significant positive effect-size values. As illustrated in Figure 1a , and showing a small effect size, sleep latency increased very progressively with age and became more obvious after 65 years of age. The same observations can be made for percentages of stage 1 and stage 2 66 USA 55 men & 64 women PSG, 5 nights TST, SE, S1, S2, S3, S4, RM 50-70 years Naifeh, 1987 33 USA 5 men and 6 women PSG, 4 nights TST, SL, SE, S1, S2, SWS, REM, WASO 61-81 years 6 men and 6 women 30-39 years Zeplin, 1987 37 USA 9 men and 9 women PSG, 3 nights SL, SWS, REM, WASO 57-71 years 9 men and 9 women 18-23 years Hoch, 1988 41 USA 9 men and 10 women PSG, 2 x 3 nights TST, SL, SE, REM, WASO 60-82 years Schiavi, 1988 11 USA 40 men, 23-73 years PSG, 3 nights TST, SE, REM Bonnet, 1989 67 USA 12 men, 55-70 years PSG, 4 nights TST, SL, S1, S2, S3, S4, REM, WASO 12 men, 18-28 years (data from baseline night after 1 night habituation) Dijk, 1989 68 Netherland 13 men & 15 women PSG, 2 nights TST, S1, S2, S3, S4, REM 19-28 years Brendel, 1990 12 USA 6 men and 4 women PSG, 3 nights TST, SL, SE, S1, S2, S3, S4, SWS, REM, mean age 83.0 years WASO 10 men and 4 women mean age 23.9 years Hoch, 1990 34 USA 49 men and 56 women PSG, 3 nights TST, SE, REM 60-91 years Vitiello, 1990 69 USA 11 men and 13 women PSG, 3 nights TST, SL, SE, S1, S2, SWS, REM, WASO mean age 63.6 years Van Coevorden, 1991 38 Belgium 8 men, 67-84 years PSG, 3 nights TST, SWS, REM 8 men, 20-27 years Lauer, 1991 13 Germany 26 men and 25 women PSG, 3 nights TST, SL, SE, S1, S2, SWS, REM, WASO mean age 38.3 years 72 UK 7 men and 5 women PSG, 2 x 2 nights TST, SE, S1, S2, SWS, REM mean age 25 years Parrino, 1998 23 Italy 20 men and 20 women PSG, 2 nights TST, SL, SE, S1, S2, S3, S4, REM, WASO ≥ 10 years Rao, 1999 36 USA 35 men and 38 women PSG, 2 nights TST, SL, SE, S1, S2, S3, S4, REM, WASO mean age between 24.2 and 42 years Spiegel, 1999 73 Switzerland 20 men and 10 women PSG, 2 nights SL, S1, S2, SWS, REM, WASO T1: 63 sleep. In both cases, there was an increase of about 5% between 20 and 70 years, which translated into small effect sizes. On the other hand, the effect size was large for WASO. It can be seen in Figure 1e that WASO consistently increased about 10 minutes per decade of age from 30 years.
All the homogeneity statistics (Q statistic) were significant ( Table 6 ), indicating that factors other than aging may be responsible for the observed differences. Results of the moderator analyses are reported in Tables 7, 8, and 9 .
Impact of Moderator Variables
Total Sleep Time
In children and adolescents, the relation between age and TST was moderated by the recording methods; studies that used inlaboratory PSG found significantly larger correlations than those using actigraphy (z statistic for contrast: -7.92; P < .0001). Similarly, the relation between age and TST was moderated by the time of recording. Studies that took place during school days (z statistic for contrast: -7.60; P < .0001) had larger correlations than those that were done on nonschool days. The results showed that TST decreased with age only when recordings took place on school days. On nonschool days, TST remained the same from childhood to the end of adolescence. In adults, exclusion of subjects with mental disorders produced a larger effect size, indicating a greater association between TST and aging when researchers excluded participants with a mental disorder compared to studies that kept such participants. The same effect on TST was observed when researchers excluded participants with physical illnesses, drug or alcohol use, or sleep apnea, or other sleep disorders ( Table 7) . Studies that kept habitual sleep patterns for the night of the PSG recording also produced a larger effect size than when researchers imposed the schedule for lights off and on. Effect size was larger in women than in men, indicating a greater association between declining TST and aging among women.
We also verified that the sample composition in terms of ageie, elderly only (60 years or older); young, middle-aged, and elderly subjects; or samples composed of young adults and elderly subjects-produced different results. The association between TST and age was higher in studies that compared young adults with middle-aged and young adults with elderly subjects. The association was nonsignificant when the researchers included only participants 60 years or older. This indicates that TST did not continue to significantly decline among older subjects.
Sleep Efficiency
Similar to the pattern seen for TST, adult studies that excluded participants with mental disorders, physical illnesses, sleep apnea, or other sleep disorders obtained a greater association between sleep efficiency and age compared to studies that included these participants. Inclusion or exclusion of drugs or alcohol had no appreciable influence on effect sizes. Again, effect size was larger in women than in men, indicating a greater association between declining sleep efficiency and aging among women. The examination of sample composition showed that, once again, a larger effect size was found in studies that compared young with elderly adults and young with middle-aged subjects; however, in contrast to what was observed for TST, sleep efficiency continued to significantly decrease with age in the "elderly only" samples where a medium effect size was observed.
Sleep Latency
As seen in Table 7 , adult studies that included participants with physical illnesses or with other sleep disorders had nonsignificant effect size for sleep latency, indicating that sleep latency did not change with age. In contrast, studies that took care to exclude such participants had medium positive effect sizes, indicating that sleep latency increased with age. Studies that included subjects with sleep apnea had significant positive effect sizes, while those that excluded them had nonsignificant effect sizes. Again, sample composition in terms of participants' ages produced different effect sizes: studies that included only elderly subjects and those that included young, middle-aged, and elderly subjects had nonsignificant effect sizes. Only when researchers compared very young adults to elderly participants was a positive association observed between sleep latency and getting older.
Percentage of Stage 1 Sleep
Moderator analyses in adults showed that the association between percentage of stage 1 sleep and age is greater when researchers excluded participants with a mental disorder, sleep apnea or other sleep disorders or taking drugs or alcohol (Table  8 ). On the other hand, inclusion or exclusion of participants with a physical illness had no impact on effect size. Larger effect size was obtained when the association between increasing percent-age of stage 1 sleep and aging was limited to women compared to when it was limited to men. Again, larger effect sizes were obtained when studies included only young and middle-aged participants or young and elderly participants.
Percentage of Stage 2 Sleep
In children and adolescents studies, as well as in adult studies, percentage of stage 2 sleep significantly increased with age.
The relation between age and percentage of stage 2 sleep in children and adolescents was somewhat influenced by the day of recording ( Table 5 ). Studies that took place during school days (z statistic for contrast: 3.05; P < .0001) had smaller effect sizes than those that were done on nonschool days (z statistic for contrast: 2.83; P < .01) or those for which there was no indication for the time of the year (z statistic for contrast: 4.39; P < .0001).
In adult samples, studies that excluded participants with mental disorders, physical illnesses, drug or alcohol use, sleep apnea, or other sleep disorders obtained larger effect sizes between aging and percentage of stage 2 sleep, while studies that kept those participants had nonsignificant effect sizes. Similarly, stud- ies that used the habitual sleep patterns of the participants to set the PSG recording obtained larger effect sizes than did studies that imposed a fixed schedule for lights off and lights on ( Table  8) .
Percentage of SWS
In children and adolescents studies, moderator analyses showed a large effect size in studies performed on nonschool days and a small effect size for studies performed on school days.
In adults, as seen in Table 8 , analyses of moderator variables did not produce different results: the exclusion or inclusion of participants with a mental disorder, physical illness, drug or alcohol use, sleep apnea, or other sleep disorders gave large effect sizes in all cases. However, it was noted that effect sizes were much larger when participants with a mental disorder, sleep apnea, or other sleep disorders were excluded. Furthermore, the use of habitual sleep patterns to set the PSG recording gave a larger size effect than in studies that imposed a fixed schedule for lights off and lights on ( Table 8) .
Effect sizes were similar in men and in women. When examining the sample composition, studies that included only elderly participants did not find changes in percentage of SWS. 
Meta
Percentage of REM Sleep
As seen with percentage of SWS, exclusion of participants with any of the moderator variables did not produce major changes in the effect sizes for mental disorder, drug or alcohol use, habitual sleep patterns, and sex. The most notable effect was observed in studies that excluded participants with other sleep disorders compared to those that kept them (Table 9 ). Once more, the effect size was not significant for studies that included only elderly individuals. Studies that compared young to elderly subjects and young to middle-aged subjects found greater effect sizes.
REM Latency
The relationship between REM latency and age was modified by the exclusion of subjects with sleep apnea or other sleep disorders (Table 9 ). In both cases, a negative association was observed between REM latency and age. Effect sizes were also larger in women than in men and in studies that kept the habitual sleep patterns of the participants. Similarly, studies that compared young to elderly participants obtained the largest effect sizes between REM latency and age; however, those studies that included only elderly participants or broader age ranges had nonsignificant effect sizes.
Wake After Sleep Onset
The exclusion of participants with a mental disorder, a physical illness, or sleep apnea or those using drugs or alcohol decreased the effect sizes, while the exclusion of participants with other sleep disorders increased the effect sizes (Table 9 ). This pattern indicates that when sleep disorders were possibly present, the association of WASO and age was weakened. Table 10 provides information about effect sizes and homogeneity tests calculated for comparisons between men and women. Negative effect sizes indicated that women had higher means than men on the sleep measures, while positive effect sizes indicated that men had higher means than women on the sleep measures. As can be seen, TST, sleep latency, percentage of SWS, percentage of REM sleep, and REM latency had negative effect sizes, indicating that men had higher means on these variables. On the other hand, percentage of stage 2 sleep and WASO had positive effect sizes, indicating higher means for women than for men. Effect sizes were in the small range for most variables (TST, sleep latency, percentage REM sleep, REM latency, and WASO), indicating that the differences between men and women on these variables were modest.
Sex Trends
DISCUSSION
This study aimed to describe age-related changes in the macrostructure of sleep and to clarify the issues regarding earlier contradictory results regarding the evolution of sleep latency and percentages of stage 1, stage 2, and REM sleep. Indeed, about half of the studies that analyzed age-related changes for percentages of REM and stage 1 sleep reported that these parameters changed with age, while the other half found no change. Similarly, about 2 of 3 studies reported that sleep latency and percentage of stage 2 sleep did not change with age, while the others found that these 2 parameters increased with age. One of the problems was that these studies based their conclusions on a small number of subjects. Therefore, it is very difficult to identify age-related trends when the changes are subtle. To summarize all this information, we decided to perform meta-analyses on 65 studies, which represented 3,577 subjects aged 5 years or older.
This method allowed quantifying conclusions, which cannot be done with traditional literature reviews. We also performed the analyses in relationship with several moderators that can have a significant impact on any potential associations between sleep and aging.
In relationship with the objectives of the study, the following conclusions can be drawn from our meta-analytic results.
(1) Sleep latency increases with age. Overall, it appeared that sleep latency modestly but significantly increased with age. However, the change is very subtle: when young adults were compared to middle-aged individuals, and middle-aged compared to elderly individuals, sleep latencies were comparable. The significant difference appeared only when very young adults were compared to elderly individuals. The overall increase in sleep latency between 20 and 80 years was less than 10 minutes.
(2) Percentage of stage 1 sleep increases with age. The significant increase in stage 1 sleep was found between young and middle-aged adults and between middle-aged and elderly individuals, which means that percentage of stage 1 sleep significantly increased across all adulthood.
(3) Percentage of stage 2 sleep increases with age. This increase was present across the full age range studied, from childhood (5 years and older) until age 60. (4) Percentage of REM sleep decreases with age in adults. Percentage of REM sleep first increased from childhood to adolescence, than decreased between young and middle-aged adults, and remained unchanged in subjects older than 60 years of age. (5) In adults, the increase in the percentage of stage 2 sleep with age and the decrease of REM latency with age appeared to be very sensitive to psychiatric disorders, use of drugs or alcohol, sleep apnea, or other sleep disorders; failure to exclude individuals with these conditions resulted in the confounding of their significant associations with age.
(6) In children 5 years and older and in adolescents, the apparent decrease in TST with age appears to be related to environmental factors rather than to biologic changes. As we showed in Table 5 , the studies analyzed indicated a significant decrease of TST with age but only when recordings were performed during school days. (7) While almost all studies in children 5 years of age or older and adolescents did not find significant changes in REM sleep with age, it appeared that there actually is a modest but significant increase in the percentage of REM sleep from childhood to the end of adolescence. After that age, percentage of REM sleep remains relatively stable until 60 years of age, when it again begins to decrease.
Sleep in Children and Adolescents
Studies that examined the normal sleep in children aged 5 years or older and adolescents using PSG recordings are still scant, making it difficult to impossible to effectively perform moderator analyses and to analyze all the sleep variables examinable in the older population.
Results of the meta-analysis suggested that different recording techniques are likely to give different results. Although the conclusion for TST was the same for in-laboratory recordings and actigraphy, the association between TST and age was weaker with actigraphy (-0.33) than with in-laboratory recordings (-0.69). Furthermore, the discrepancy for TST between the different methods was large among the younger children: more than 60 minutes for children aged between 8 and 12 years.
Importantly, the timing of the recording influenced the agerelated change for several sleep variables. Thus, the reduction in TST with age was significant only when recordings were made during school days; TST was unassociated with age when studied on nonschool days. This pattern suggests that, in children and adolescents, the decrease in TST is not related to maturation but to other factors such as school schedules. Several North American studies have reported the difficulties adolescents have in adjusting to early school days, which occurs for older rather than younger children. 76 Sleep latency and sleep efficiency remained largely unchanged from childhood to adolescence, and none of the studies in the meta-analysis reported significant age-related changes for these 2 sleep parameters.
Percentage of stage 2 sleep was found to increase with age, while percentage of SWS decreased. These 2 results were also found individually in the 5 studies that examined these 2 parameters. Of note, however, is a very large difference between results using the ambulatory monitoring system and in-laboratory recording, which may be attributed to methodologic differences in the studies.
The results of the meta-analysis suggested that the percentage of REM sleep significantly (but modestly) increased with age, an unexpected finding since the studies that examined this parameter did not find this association. 26, 49, 52, 53, 58, 59 Since the effect size is small, it would have been difficult to identify this association without the quantitative assessment provided by the meta-analysis.
Sleep in Adults
As expected, TST and sleep efficiency consistently decreased with age. WASO obtained the largest effect size, showing the important increase with age of time awake after sleep onset. Sleep latency and percentage of stage 2 sleep increased with age, but the associations were small (.27 and 0.28, respectively). Percentage of SWS and REM sleep both also decreased. In addition, small effect sizes were obtained for percentage of stage 1 sleep and REM latency; the first increasing with age, and the other decreasing with age. From the results of this meta-analysis, it is clear that all studied sleep parameters significantly change with age across the adult lifespan.
Roles of Moderator Variables
A great advantage of meta-analyses includes its potential to explore the role of different moderators on the association between aging and different sleep variables.
The analyses of potential moderators brought to light a number of noteworthy observations. Failure to exclude participants with a mental disorder had several significant consequences on the results: (1) it diminished the associations of TST and sleep efficiency with age, that is, the decreases observed in TST and sleep efficiency were less pronounced when participants were not screened for mental disorders; (2) it hid the age-related increase of percentage of stage 2 sleep; and (3) it hid the age-related diminution of REM latency.
A similar pattern was observed with medical illness. Failure to exclude participants with medical illness resulted in considerably diminished associations of TST and sleep efficiency with age and also obscured the relationship between aging and increased sleep latency. Exclusion of participants with sleep apnea had important modifications on effect sizes for the TST; percentages of stage 1, stage 2, and REM sleep; and REM latency. Indeed, studies that did not screen participants for sleep apnea had smaller effect sizes on these variables, which indicated that age-related changes were less pronounced.
Using predetermined light off and light on time instead of the habitual sleep schedule of the participants also had consequences for the results: the observed decrease in TST with age was smaller and the significant increase of percentage of stage 2 sleep and the significant decrease in REM latency with age disappeared.
Why are the age effects less obvious with the inclusion of these disorders? There is no simple explanation for this fact. First, it is impossible to determine how many subjects were suffering from 1 or several of the diseases included in the moderator analyses. However, in small samples, the inclusion of some not perfectly healthy subjects creates a heterogeneous group, and it is enough to influence the results in unexpected ways. This is a very different situation than when the purpose of the research is to measure the effects of a disease on sleep architecture; in this case the subjects of the experimental group all have the disease, and some conclusions can be drawn. Second, the evolution of sleep architecture with age in specific diseases is not well known: studies usually used age-matched controls to measure the effect of the disease on sleep architecture-which is a methodologically sound; however, this does not provide information on the evolution of sleep architecture with age. Furthermore, participants in the studies included in the meta-analysis were all from nonclinical populations. It is unlikely that individuals with a severe mental disorder were included in the studies even when no screening was done to exclude mental disorders. It has been repeatedly demonstrated, however, that mild or moderate mental disorders such as anxiety or depression are often accompanied by sleep complaints. It is therefore reasonable to assume that the presence of such low-grade mental disorders may have adversely impacted sleep-age relationships. The same conjecture can be made about medical illnesses.
The sex analyses showed that the associations between sleep variables and aging were generally the same for both sexes; however, larger effect sizes were observed in women for TST, sleep efficiency, percentage of stage 1 sleep, and REM latency, indicating that the age effect on these variables were more important in women. On the other hand, effect sizes calculated for sex indicated that women have longer TST and sleep latency than similarly aged men. They also have less percentage of stage 2 sleep and greater percentage of SWS than age-matched men.
Interestingly, Figures 1c and 1d clearly illustrate that percentages of SWS and REM sleep that were based on in-laboratory studies decrease with age. The diminution in the percentage of SWS can be readily observed in childhood and continues steadily until old age. Conversely, for REM sleep, the overall data pattern (see Figure 1d ) may explain disagreements among previous studies concerning the evolution of this sleep stage with age. Meta-analytic results indicated that the percentage of REM sleep decreased with age from young adulthood to late middle age, but the decrease is not significant in individuals over 60 years of age. 
Meta
Limitations
This meta-analysis is not without limitations. For many studies, it was impossible to calculate effect sizes related to age and sex because no information was given in relation with the presence or absence of sex differences. Therefore, we had to discard several studies with otherwise usable data. Effect sizes can be calculated from different statistical information, but a minimum is needed. The same can be said for race. Most of the studies did not include information about the race composition of the sample. It was therefore impossible to include race as a moderator variable, as had been originally planned.
Several studies did not include middle-aged subjects. This is quite obvious in the Figures, where a concentration of information can be observed at both extremes: young adults and elderly participants. One of the consequences of this was to maximize the effect sizes related to age. In the sample composition moderator, we wanted to measure the effect size for the progression between young and middle-aged and between middle-aged and elderly subjects. This more-complex analysis showed that age progressions for all of the sleep variables were much more subtle than when a simple comparison of young to elderly subjects was made.
Another limitation may have come from our decision to limit our sample to peer-reviewed studies. It is known that, for clinical trials, the limitation to peer-reviewed reports might introduce a small bias on effect sizes because published studies often favor significant findings. On the other hand, this issue is less likely to have played a role in our study, since the reports used in the metaanalysis were mostly purely descriptive, aimed at describing agerelated changes of sleep in the population.
Conclusions and Recommendations
Accurate normative data on the evolution of sleep architecture across the human life span are important to better understand exactly what type of changes in sleep patterns can be expected as individuals are aging. The main findings of this study are summarized in Table 11 . The evolution with age of the different sleep stages, REM sleep, and WASO is shown in Figure 2 . In summary, and in contrast to what was generally suggested in several small studies, the TST in children 5 years of age or older and adolescents did not really change with age. It appeared to be related to environmental factors rather than to biologic changes. There was a modest but significant increase in the percentage of REM sleep from childhood to the end of adolescence. After that age, percentage of REM sleep remained relatively stable until 60 years of age, when the percentage again began to decline. Sleep latency modestly but significantly increased with age. However, the change was very subtle and was apparent when very young adults were compared to elderly individuals. Percentage of stage 1 sleep increased with age through all adulthood. Percentage of stage 2 sleep increased with age from childhood (5 years and older) until old age. After 60 years of age, only sleep efficiency continued to significantly decrease, with all the other sleep parameters remaining unchanged.
The results of the meta-analysis clearly illustrated the importance of strict screening methods for the study of sleep parameters in healthy individuals, as it maximizes the emergence of agerelated changes in sleep. As was demonstrated, inclusion of individuals with sleep, organic, or psychiatric disorders, as well as the modification of habitual sleep time, substantially obliterated the importance of changes in sleep patterns with aging.
There are several aspects of normal sleep that need to be further investigated: racial comparisons of sleep patterns are still poorly documented; polysomnographic data in healthy children and adolescents, and to a somewhat lesser degree in middle-aged adults, are still scant. Any future studies aimed at examining agerelated changes in sleep should utilize carefully screened subjects and take into account subjects' habitual sleep schedules, as well as whether PSG recording occurs on weekday or weekend nights.
